oncnursingnews3h
Adding Lenvatinib/Pembrolizumab to TACE Extends PFS in Unresectable Liver Cancer
The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
oncnursingnews7h
Investigational Nasal Spray May Improve Symptoms in Cancer Cachexia
Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.
oncnursingnews22h
Sotorasib Plus Panitumumab Receives FDA Approval for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved sotorasib with panitumumab for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC) ...
oncnursingnews23h
FDA Approves Acalabrutinib-Based Regimen for Previously Treated MCL
The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...